Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Corvus Pharmaceuticals, Inc. | crvs-20201231xex32d1.htm |
| EX-31.2 - EX-31.2 - Corvus Pharmaceuticals, Inc. | crvs-20201231xex31d2.htm |
| EX-31.1 - EX-31.1 - Corvus Pharmaceuticals, Inc. | crvs-20201231xex31d1.htm |
| EX-21.1 - EX-21.1 - Corvus Pharmaceuticals, Inc. | crvs-20201231xex21d1.htm |
| EX-4.5 - EX-4.5 - Corvus Pharmaceuticals, Inc. | crvs-20201231xex4d5.htm |
| 10-K - 10-K - Corvus Pharmaceuticals, Inc. | crvs-20201231x10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-237040), and Form S-8 (No. 333-223622, No. 333-216590, No. 333-210456, No. 333-231331 and No. 333-237933) of Corvus Pharmaceuticals. Inc. of our report dated March 25, 2021 relating to the financial statements, which appear in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
San Jose, California
March 25, 2021